SCHEMBL2952223

SCHEMBL2952223

C1CCCN2CCCCC/C2=N\CC1

nearest known ligand 0.91

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
INMT O95050 4/20 0.91
USP2 O75604 2/20 0.91
NOS3 P29474 5/20 0.41
NOS1 P29475 5/20 0.41
NOS2 P35228 5/20 0.41
ACHE P22303 5/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ALDH1A1 P00352 2/20 0.34
TSHR P16473 1/20 0.34
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL496207 1.00 INMT (0.91) INMTUSP2NOS3NOS1NOS2
SCHEMBL219036 1.00 INMT (0.91) INMTUSP2NOS3NOS1NOS2
SCHEMBL6859113 1.00 INMT (0.91) INMTUSP2NOS3NOS1NOS2
SCHEMBL5475300 1.00 INMT (0.91) INMTUSP2NOS3NOS1NOS2
SCHEMBL2956216 1.00 INMT (0.91) INMTUSP2NOS3NOS1NOS2
SCHEMBL3270217 1.00 INMT (0.91) INMTUSP2NOS3NOS1NOS2
SCHEMBL2956214 1.00 INMT (0.91) INMTUSP2NOS3NOS1NOS2
SCHEMBL6038391 1.00 INMT (0.91) INMTUSP2NOS3NOS1NOS2
SCHEMBL2742282 1.00 INMT (0.91) INMTUSP2NOS3NOS1NOS2
SCHEMBL20718625 1.00 INMT (0.91) INMTUSP2NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2785726-B1 ESTER-FUNCTIONAL SILANES AND THE PREPARATION AND USE THEREOF; AND USE OF IMINIUM COMPOUNDS AS PHASE TRANSFER CATALYSTS DOW SILICONES CORP (US) 2018-08-01 EP disclosed
EP-2573092-B1 Method for the preparation and use of bis (alkoxysilylorgano)-dicarboxylates DOW CORNING (US) 2017-03-29 EP disclosed
US-9518072-B2 Ester-functional silanes and the preparation and use thereof; and use of iminium compounds as phase transfer catalysts DOW CORNING CORPORATION (US) 2016-12-13 US disclosed
EP-1963389-B1 FAST CURING ALIPHATIC RIM ELASTOMERS COVESTRO LLC (US) 2015-11-11 EP disclosed
US-20150126676-A1 Ester-Functional Silanes And The Preparation And Use Thereof; And Use Of Iminium Compounds As Phase Transfer Catalysts DOW SILICONES CORPORATION 2015-05-07 US disclosed
US-8580886-B2 Method for the preparation and use of bis (alkoxysilylorgano)-dicarboxylates DOW CORNING CORPORATION (US) 2013-11-12 US disclosed
EP-2573092-A1 Method for the preparation and use of bis (alkoxysilylorgano)-dicarboxylates Dow Corning Corporation (US) 2013-03-27 EP disclosed
US-20130072625-A1 Method for the Preparation and Use of Bis (Alkoxysilylorgano)-Dicarboxylates DOW CORNING CORPORATION (US) 2013-03-21 US disclosed
US-7772353-B2 Fast curing aliphatic RIM elastomers BAYER MATERIALSCIENCE LLC (US) 2010-08-10 US disclosed
EP-1963390-B1 RIM ELASTOMERS BASED ON ISOCYANURATES OF ISOPHORONE DIISOCYANATE AND PREPOLYMERS THEREOF BAYER MATERIALSCIENCE LLC (US) 2010-06-23 EP disclosed
US-20070142601-A1 RIM elastomers based on isocyanurates of isophorone diisocyanate and prepolymers thereof BAYER MATERIALSCIENCE LLC 2007-06-21 US disclosed
US-20070142609-A1 Fast curing aliphatic RIM elastomers BAYER MATERIALSCIENCE LLC 2007-06-21 US disclosed
US-20070142607-A1 Weather resistant polyurethane elastomer BAYER MATERIALSCIENCE LLC 2007-06-21 US disclosed
US-20070142610-A1 Polyurethane elastomers comprising allophanate modified isocyanates BAYER MATERIAL SCIENCE LLC 2007-06-21 US disclosed
US-6794530-B1 1,4-ADDITION OF MONOHYDRIC OR POLYHYDRIC ALCOHOLS TO ALPHA , BETA -UNSATURATED NITRILES BASF AKTIENGESELLSCHAFT (DE) 2004-09-21 US disclosed
EP-0934925-B1 Process for the preparation of beta-alkoxy nitriles BASF AG (DE) 2002-09-25 EP disclosed
US-6166207-A Preparation of bicyclic amidines and diazacycloalkenes BASF AKTIENGESELLSCHAFT (DE) 2000-12-26 US disclosed
US-6130347-A REACTING MONOCHLOROACETIC ESTER WITH HYDROGEN CYANIDE IN BASE PRESENCE; CYANATION BASF AKTIENGESELLSCHAFT (DE) 2000-10-10 US disclosed
EP-0934925-A1 Process for the preparation of beta-alkoxy nitriles BASF AKTIENGESELLSCHAFT (DE) 1999-08-11 EP disclosed
EP-0080171-B1 HEAT-INSULATING MOULDING AND PROCESS FOR PREPARING THE SAME Hitachi, Ltd. (JP) 1988-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130072625-A1 Method for the Preparation and Use of Bis (Alkoxysilylorgano)-Dicarboxylates PBRM1, IPMK, BOLA2; BOLA2B INMT 253/4885USP2 2679/4885NOS3 4620/4885
US-20150126676-A1 Ester-Functional Silanes And The Preparation And Use Thereof; And Use Of Iminium Compounds As Phase Transfer Catalysts ICMT, INTS9, HDHD5 INMT 4/4885USP2 4321/4885NOS3 2510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.